| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 935 | 2013 |
| Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary … D Sibbing, D Aradi, D Alexopoulos, J Ten Berg, DL Bhatt, L Bonello, ... JACC: Cardiovascular Interventions 12 (16), 1521-1537, 2019 | 482 | 2019 |
| Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI GN Levine, Y Jeong, S Goto, JL Anderson, Y Huo, JL Mega, K Taubert, ... Nature reviews. Cardiology 11 (10), 597, 2014 | 308 | 2014 |
| Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL … YH Jeong, SW Lee, BR Choi, IS Kim, MK Seo, CH Kwak, JY Hwang, ... Journal of the American College of Cardiology 53 (13), 1101-1109, 2009 | 231 | 2009 |
| Optimal timing of coronary invasive strategy in non–ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis EP Navarese, PA Gurbel, F Andreotti, U Tantry, YH Jeong, M Kozinski, ... Annals of internal medicine 158 (4), 261-270, 2013 | 203 | 2013 |
| The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease HK Kim, US Tantry, SC Smith Jr, MH Jeong, SJ Park, MH Kim, DS Lim, ... Thrombosis and haemostasis 121 (04), 422-432, 2021 | 194 | 2021 |
| The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study PA Gurbel, KP Bliden, DK Logan, DJ Kereiakes, KC Lasseter, A White, ... Journal of the American College of Cardiology 62 (6), 505-512, 2013 | 180 | 2013 |
| Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific … FKL Chan, KL Goh, N Reddy, K Fujimoto, KY Ho, S Hokimoto, YH Jeong, ... Gut 67 (3), 405-417, 2018 | 169 | 2018 |
| “East asian paradox”: challenge for the current antiplatelet strategy of “one-guideline-fits-all races” in acute coronary syndrome YH Jeong Current cardiology reports 16, 1-8, 2014 | 167 | 2014 |
| Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors … YH Jeong, US Tantry, IS Kim, JS Koh, TJ Kwon, Y Park, SJ Hwang, ... Circulation: Cardiovascular Interventions 4 (6), 585-594, 2011 | 163 | 2011 |
| Diagnostic approach and treatment strategy in tachycardia‐induced cardiomyopathy YH Jeong, KJ Choi, JM Song, ES Hwang, KM Park, GB Nam, JJ Kim, ... Clinical Cardiology: An International Indexed and Peer‐Reviewed Journal for …, 2008 | 148 | 2008 |
| Acute coronary syndrome in the Asia-Pacific region MY Chan, X Du, D Eccleston, C Ma, PP Mohanan, M Ogita, KG Shyu, ... international Journal of Cardiology 202, 861-869, 2016 | 147 | 2016 |
| Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel JS Jang, KI Cho, HY Jin, JS Seo, TH Yang, DK Kim, DS Kim, SH Seol, ... The American journal of cardiology 110 (4), 502-508, 2012 | 140 | 2012 |
| Racial differences in ischaemia/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs J Kang, KW Park, T Palmerini, GW Stone, MS Lee, A Colombo, A Chieffo, ... Thrombosis and haemostasis 119 (01), 149-162, 2019 | 124 | 2019 |
| Carriage of Cytochrome 2C19 Polymorphism Is Associated With Risk of High Post-Treatment Platelet Reactivity on High Maintenance-Dose Clopidogrel of 150 mg … YH Jeong, IS Kim, Y Park, MK Kang, JS Koh, SJ Hwang, CH Kwak, ... JACC: Cardiovascular Interventions 3 (7), 731-741, 2010 | 121 | 2010 |
| Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an … CJ Kim, MW Park, MC Kim, EH Choo, BH Hwang, KY Lee, YS Choi, ... The Lancet 398 (10308), 1305-1316, 2021 | 120 | 2021 |
| Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: results … YH Jeong, JY Hwang, IS Kim, Y Park, SJ Hwang, SW Lee, CH Kwak, ... Circulation: Cardiovascular Interventions 3 (1), 17-26, 2010 | 120 | 2010 |
| Association of cytochrome P450 2C19* 2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents IY Oh, KW Park, SH Kang, JJ Park, SH Na, HJ Kang, BK Koo, YH Jeong, ... Heart 98 (2), 139-144, 2012 | 119 | 2012 |
| The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies KP Bliden, US Tantry, RF Storey, YH Jeong, M Gesheff, C Wei, PA Gurbel American heart journal 162 (1), 160-165, 2011 | 114 | 2011 |
| Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies YH Jeong, KP Bliden, MJ Antonino, KS Park, US Tantry, PA Gurbel American heart journal 164 (1), 35-42, 2012 | 113 | 2012 |
Paul GurbelSinai Center for Thrombosis Research and Drug Development在 lifebridgehealth.org 的电子邮件经过验证
